India to United States: Mesalamine Export Trade Route
India has recorded 753 verified shipments of Mesalamine exported to United States, representing a combined trade value of $1.2B USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $1.6M USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED, which accounts for 79% of total export value with 297 shipments worth $953.0M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $993.2M USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CADILA HEALTHCARE LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Mesalamine corridor is one of India's established pharmaceutical export routes, with 753 shipments documented worth a combined $1.2B USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's mesalamine manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $1.6M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with mesalamine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 21.3%, placing it at rank #3 among India's top mesalamine export destinations globally.
On the import side, key buyers of Indian mesalamine in United States include EVERSANA LIFE SCIENCE SERVICES, SUN PHARMACEUTICAL INDUSTRIES, INC., NORTHSTAR DISTRIBUTION CENTER 8912 and 42 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 268 shipments valued at $993.2M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#3
- Annual growth+21.3%
- Demand growth+18.1%
- Regulatory ease73/100
Top 10 Indian Mesalamine Exporters to United States
Showing top 10 of 15 Indian suppliers exporting Mesalamine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED Avg $3.2M per shipment | 297 | $953.0M | 79.0% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $1.7M per shipment | 99 | $166.6M | 13.8% |
| 3 | CADILA HEALTHCARE LIMITED Avg $1.4M per shipment | 32 | $46.4M | 3.8% |
| 4 | ANNORA PHARMA PRIVATE LIMITED Avg $132.0K per shipment | 132 | $17.4M | 1.4% |
| 5 | CADILA HEALTHCARE LTD Avg $1.1M per shipment | 9 | $9.7M | 0.8% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $303.4K per shipment | 14 | $4.2M | 0.4% |
| 7 | ALKEM LABORATORIES LIMITED Avg $75.4K per shipment | 45 | $3.4M | 0.3% |
| 8 | ENCUBE ETHICALS PRIVATE LIMITED Avg $32.4K per shipment | 74 | $2.4M | 0.2% |
| 9 | ALEMBIC PHARMACEUTICALS LIMITED Avg $29.6K per shipment | 37 | $1.1M | 0.1% |
| 10 | MYLAN LABORATORIES LIMITED Avg $198.8K per shipment | 4 | $795.1K | 0.1% |
This table shows the top 10 of 15 Indian companies exporting mesalamine to United States, ranked by total trade value. The listed exporters are: ZYDUS LIFESCIENCES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CADILA HEALTHCARE LIMITED, ANNORA PHARMA PRIVATE LIMITED, CADILA HEALTHCARE LTD, SUN PHARMACEUTICAL INDUSTRIES LTD, ALKEM LABORATORIES LIMITED, ENCUBE ETHICALS PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED. ZYDUS LIFESCIENCES LIMITED is the dominant supplier with 297 shipments worth $953.0M USD, giving it a 79% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Showing top 10 of 15 total Indian exporters on the India to United States Mesalamine export route.
Top 10 Mesalamine Importers in United States
Showing top 10 of 45 known buyers in United States receiving Mesalamine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian mesalamine in United States include EVERSANA LIFE SCIENCE SERVICES, SUN PHARMACEUTICAL INDUSTRIES, INC., NORTHSTAR DISTRIBUTION CENTER 8912, SUN PHARMACEUTICAL INDUSTRIES INC, TO THE ORDER OF, among 45 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $993.2M USD across 268 shipments — representing 82% of all mesalamine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 268 | $993.2M | 82.4% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES, INC. | 15 | $148.6M | 12.3% |
| 3 | NORTHSTAR DISTRIBUTION CENTER 8912 | 63 | $13.1M | 1.1% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES INC | 37 | $11.5M | 1.0% |
| 5 | TO THE ORDER OF | 72 | $7.1M | 0.6% |
| 6 | TO THE ORDER OF.... | 28 | $5.8M | 0.5% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 27 | $4.0M | 0.3% |
| 8 | XXN PXXRMAXXUTIXXL IXXUSTXXES XXC | 3 | $4.0M | 0.3% |
| 9 | NORTHSTAR DISTRIBUTION CENTER | 3 | $2.2M | 0.2% |
| 10 | ASCEND LABORATORIES,LLC | 26 | $1.6M | 0.1% |
Showing top 10 of 45 Mesalamine importers in United States on this route.
Top 10 Mesalamine Formulations Imported by United States
Showing top 10 of 299 product formulations shipped on the India to United States Mesalamine route, ranked by trade value
United States imports a wide range of mesalamine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA : MESALAMINE DR TABLETS USP 800MG(MESALAMINE DR USP 800MG) - 5388 BTLS X1X180 TABS — accounts for $387.9M USD across 1 shipments. There are 299 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA : MESALAMINE DR TABLETS USP 800MG(MESALAMINE DR USP 800MG) - 5388 BTLS X1X180 TABS | 1 | $387.9M | 32.2% |
| 2 | PHARMA : MESALAMINE DR TABLETS USP 800MG(MESALAMINE DR USP 800MG) - 5316 PAC X1X180 TABS | 1 | $382.8M | 31.7% |
| 3 | MESALAMINE DELAYED RELEASE TABLETS 1.2GM[9353 PACKS X 1X120'S] (BATCH NO. DNE1294A, DNE1282A, DNE1293A, DNE1284A, DNE12 | 1 | $60.5M | 5.0% |
| 4 | MESALAMINE DELAYED RELEASE TABLETS 1.2GM[8864 PACKS X 1X120'S] (BATCH NO. DNE1267A, DNE1198A, DNE1280A MFG.DT. 10/23 EX | 1 | $57.3M | 4.8% |
| 5 | MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | 67 | $53.3M | 4.4% |
| 6 | MESALAMINE DELAYED RELEASE TABLETS 1.2GM[4680 PACKS X 1X120'S] | 1 | $30.3M | 2.5% |
| 7 | MESALAMINE DR TAB USP 800 MG 1 X 180 | 8 | $15.0M | 1.2% |
| 8 | PHARMA : MESALAMINE DR TABLETS USP 800MG | 4 | $12.2M | 1.0% |
| 9 | MESALAMINE ER CAPS USP 500MG120'SUSA-C | 6 | $9.8M | 0.8% |
| 10 | MESALAMINE DELAYED RELEASE TABLETS 1.2 G | 6 | $9.1M | 0.8% |
Showing top 10 of 299 Mesalamine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 180 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's mesalamine exports to United States are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 297 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CADILA HEALTHCARE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $1.6M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma : mesalamine dr tablets usp 800mg(mesalamine dr usp 800mg) - 5316 pac x1x180 tabs and mesalamine delayed release tablets 1.2gm[9353 packs x 1x120's] (batch no. dne1294a, dne1282a, dne1293a, dne1284a, dne12, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 268 shipments worth $993.2M USD — representing 82% of all mesalamine imports from India on this route. A total of 45 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.2B
- Avg. Shipment
- $1.6M
- Suppliers
- 15
- Buyers
- 45
- Transit (Sea)
- ~27 days
- Annual Growth
- +21.3%
Related Analysis
Reverse Direction
United States → India — Mesalamine (Import)Other Mesalamine Routes
Unlock the Full India to United States Mesalamine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 753 shipments on this route.
Frequently Asked Questions — India to United States Mesalamine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Mesalamine to United States?
The leading Indian exporters of Mesalamine to United States are ZYDUS LIFESCIENCES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CADILA HEALTHCARE LIMITED. ZYDUS LIFESCIENCES LIMITED holds the largest market share at approximately 79% of total trade value on this route.
Q What is the total value of Mesalamine exports from India to United States?
India exports Mesalamine to United States worth approximately $1.2B USD across 753 recorded shipments. The average value per shipment is $1.6M USD.
Q Which ports does India use to ship Mesalamine to United States?
The most active port of origin is SAHAR AIR with 180 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 20% by air.
Q How long does shipping take from India to United States for Mesalamine?
The average transit time for Mesalamine shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Mesalamine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.3% with demand growth tracking at 18.1%. The route is ranked #3 among India's top Mesalamine export destinations globally.
Q How many suppliers are active on the India to United States Mesalamine route?
There are currently 15 active Indian suppliers exporting Mesalamine to United States. The market is moderately concentrated with ZYDUS LIFESCIENCES LIMITED accounting for 79% of total shipment value.
Q Who are the main importers of Mesalamine from India in United States?
The leading importers of Indian Mesalamine in United States include EVERSANA LIFE SCIENCE SERVICES, SUN PHARMACEUTICAL INDUSTRIES, INC., NORTHSTAR DISTRIBUTION CENTER 8912, SUN PHARMACEUTICAL INDUSTRIES INC, TO THE ORDER OF. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 268 shipments worth $993.2M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Mesalamine.
- 2.Supplier/Buyer Matching: 15 Indian exporters and 45 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 753 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
753 Verified Shipments
15 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists